Institutional Ownership
Lianbio Adr
CUSIP 53000N108COMLIANYQ1 2026
13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
53.5%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
9 filings · latest Nov 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2024 | Tang Capital Management LLC | 13G | 7.5% | 8.05M | SEC |
| 2 | Feb 29, 2024 | Perceptive Advisors LLC | 13D/A | 53.4% | 57.85M | SEC |
| 3 | Nov 30, 2023 | Tang Capital Partners LP | 13D | 8.6% | 9.32M | SEC |
| 4 | Nov 1, 2023 | Tang Capital Partners LP | 13G | 9.0% | 9.65M | SEC |
| 5 | Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/A | 4.4% | 4.79M | SEC |
| 6 | Nov 14, 2022 | Ra Capital Management, L.P. | 13G/A | — | — | SEC |
| 7 | Nov 15, 2021 | Perceptive Advisors LLC | 13D | 53.5% | 56.32M | SEC |
| 8 | Nov 15, 2021 | Ra Capital Management, L.P. | 13G | 7.3% | 7.66M | SEC |
| 9 | Nov 10, 2021 | Venrock Healthcare Capital Partners II, L.P. | 13G | 5.1% | 5.38M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fny Investment Advisers, LLC | 14.0K | $1 |